Form D · Biotechnology
EnteroTrack, LLC
Aurora, CO · CIK 0001612812
Offering snapshot reported Sep 25, 2026 · SEC filing
- Reported sold
- $2M Offering amount: $2M
- Investors reported
- 4 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Sep 15, 2026 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Sep 25, 2026 | Initial | $2,000,000 | No comparison | 4 | SEC filing |
| Jun 4, 2021 | Initial | $4,660,000 | No comparison | 1 | SEC filing |
| Jul 9, 2014 | Initial | $250,000 | No comparison | 1 | SEC filing |
Offering details
- Securities
- Debt, Security to be acquired, Other
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-598927
Convertible Notes
Source: Form D, filed Sep 25, 2026. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No matching detailed fund disclosure was found in the latest imported ADV filings. This does not establish that the issuer has no adviser.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Steven J. Ackerman | Director |
| Glenn T. Furuta | Director |
| Jeffrey Harrington | Director |
| Robin Shandas | Director, Executive |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
12675 E. Montview Boulevard Suite 215 Lc
Aurora, CO, 80045
Phone: 720-724-4196
Aurora, CO, 80045
Phone: 720-724-4196